AndzonBio2 | Finanzwire

Basculer en Français

11166	Companies
246602	Keywords
174550	Articles
133185	Press releases

Home
Companies
AndzonBio2

BRIEF

published on 05/13/2026 at 09:25, 5 months ago

AndzonBio2, University of Cambridge, and Cambridge Enterprise Collaborate on Neuroinflammation Therapeutics

Drug Discovery Collaboration Neurodegenerative Diseases Therapeutic Development Neuroinflammation
PRESS RELEASE

published on 05/13/2026 at 09:20, 5 months ago

AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
AndzonBio2 partners with ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop innovative neuroinflammation therapeutics, targeting neurodegenerative diseases like Parkinson's and Alzheimer's

Therapeutics Neuroinflammation AndzonBio2 ALBORADA Drug Discovery Institute Cambridge Enterprise

Accesswire

Published on 10/13/2026 at 15:00, 18 minutes ago

Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Published on 10/13/2026 at 14:45, 33 minutes ago

Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
Published on 10/13/2026 at 14:31, 47 minutes ago

First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
Published on 10/13/2026 at 14:10, 1 hour 8 minutes ago

NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 1 hour 18 minutes ago

Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE

EQS Group

Published on 10/13/2026 at 15:06, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/13/2026 at 15:05, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/13/2026 at 15:05, 12 minutes ago

Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats
Published on 10/13/2026 at 15:03, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/13/2026 at 15:02, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc

Les Echos

Published on 10/13/2026 at 09:04, 6 hours 13 minutes ago

Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 21 hours 18 minutes ago

Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

Weekly share buyback
Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 23 hours 30 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE